CD8A and neoplasm: CXCL-9 is an IFN-γ inducible chemokine that attracts various CXCR-3-expressing effector immune cells including CD8+ and CD4+ T-cells and also NK cells, and thereby changes the tumor microenvironment to an anti-tumor phenotype [239,240,241].